StockIQ.techAbbott Laboratories (ABT) Stock Analysis
Free AI-powered analysis and research for Abbott Laboratories stock
Sector: Healthcare
ABT snapshot
Data as of 12 Oct 2026 close. Updated daily.
Abbott Laboratories scores 36/100 on StockIQ's model, which reads as negative signals overall. The price is below its 200-day average and at 39% of its 52-week range, down 22.5% over the past year. Latest reported figures show a profit margin of 11.6%, return on equity of 10.6% and revenue growth of +13.0%.
What is driving the score
- RSI Neutral: +5
- Downtrend: -3
- MACD Bullish: +8
- High P/E (33.6): -10
- Good Profit Margin (11.6%): +5
- Weak Liquidity (1.38 Current Ratio): -5
- Below MA200: -4
- Severe Underperformance (-22.5% over 1 year): -10
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ABT report
Abbott Laboratories (ABT) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ABT Now →📰 Latest Update
Abbott (ABT) Gains As Market Dips: What You Should Know
Mon, October 12, 2026 at 9:00 PM UTC 2 min read
Abbott (ABT) saw its stock price increase despite a broader market downturn, indicating strong investor confidence in the company's fundamentals. This resilience may suggest that Abbott's performance is less correlated with market fluctuations, making it an attractive option for investors seeking stability. As the market remains volatile, Abbott's ability to maintain gains could signal potential for continued growth and a safe haven for investment.